Home > News > JCTH receives the first impact factor of 4.108

Time: July 1, 2021


Journal of Clinical and Translational Hepatology (JCTH) has received its first impact factor of 4.108, ranked as 42 among 92 journals in gastroenterology and hepatology, quartile in category Q2, according to the Journal Citation Report released by Clarivate Analytics on June 30, 2021.

 

JCTH is owned by the Second Affiliated Hospital of Chongqing Medical University and published by Xia & He Publishing Inc. It publishes articles on both basic and clinical liver disease research. The translational application of basic science, including methods of clinical research, is a distinctive feature of the Journal. JCTH was launched in 2013 and has been included in PubMed Central and PubMed since July 2015, in Scopus since May 2020, and in SCIE since November 2020.In June 2021, JCTH also received its first CiteScore of 6.7 released by Elsevier, ranked as 16 among 62 hepatology journals.